Zygomycosis in Solid Organ Transplant Recipients: A Prospective, Matched Case‐Control Study to Assess Risks for Disease and Outcome | Zendy

Nina Singh | Zendy; José María Aguado | Zendy; Hugo Bonatti | Zendy; Graeme N. Forrest | Zendy; Krishan Lal Gupta | Zendy; Nasia Safdar | Zendy; George John | Zendy; Kenneth Pursell | Zendy; Patricia Muñóz | Zendy; Robin Patel | Zendy; Jesús Fortün | Zendy; Pilar MartínDávila | Zendy; Bruno Philippe | Zendy; F. Philit | Zendy; Alexis Tabah | Zendy; Nicolas Terzi | Zendy; Valérie Châtelet | Zendy; Shimon Kusne | Zendy; Nina M. Clark | Zendy; Emily A. Blumberg | Zendy; Marino Blanes Juliá | Zendy; Abhi Humar | Zendy; Sally Houston | Zendy; Cornelia LassFlörl | Zendy; Leonard Johnson | Zendy; Erik R. Dubberke | Zendy; Michelle Barron | Zendy; Olivier Lortholary | Zendy

Open Access

Zygomycosis in Solid Organ Transplant Recipients: A Prospective, Matched Case‐Control Study to Assess Risks for Disease and Outcome

Author(s) -

Nina Singh,

José María Aguado,

Hugo Bonatti,

Graeme N. Forrest,

Krishan Lal Gupta,

Nasia Safdar,

George John,

Kenneth Pursell,

Patricia Muñóz,

Robin Patel,

Jesús Fortün,

Pilar MartínDávila,

Bruno Philippe,

F. Philit,

Alexis Tabah,

Nicolas Terzi,

Valérie Châtelet,

Shimon Kusne,

Nina M. Clark,

Emily A. Blumberg,

Marino Blanes Juliá,

Abhi Humar,

Sally Houston,

Cornelia LassFlörl,

Leonard Johnson,

Erik R. Dubberke,

Michelle Barron,

Olivier Lortholary

Publication year - 2009

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/605445

Subject(s) - medicine , zygomycosis , prospective cohort study , disease , intensive care medicine , outcome (game theory) , case control study , surgery , dermatology , antifungal , amphotericin b , mathematics , mathematical economics

Clinical characteristics, risks, and outcomes in solid organ transplant (SOT) recipients with zygomycosis in the era of modern immunosuppressive and newer antifungal agent use have not been defined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research